Responses
Abstracts
209 Attainment of low disease activity and remission with atacicept in patients with systemic lupus erythematosus and high disease activity in the phase IIb ADDRESS II study and its long-term extension
Compose a Response to This Article
Other responses
No responses have been published for this article.